The growing use of various modern and traditional contraceptive drugs is increasing the concerns for infertility in North America. Over the forecast period of 2018-2026, the North America in-vitro fertilization market is projected to account for a revenue of nearly $xx million, rising at a CAGR of 10.11%.

NORTH AMERICA IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

North America In-vitro Fertilization Market by Product (Reagents, Equipment) by Procedure (ICSI, PGD, FET/FER) by End-user (Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) by  Geography

Request free sample

The growing use of various modern and traditional contraceptive drugs is increasing the concerns for infertility in North America. Over the forecast period of 2018-2026, the North America in-vitro fertilization market is projected to account for a revenue of nearly $xx million, rising at a CAGR of 10.11%.

According to the United Nations, in the year 2015, the North America region accounted for nearly 75% of the global contraception market. The U.S market presently dominates the North American region, and it is expected to continue its reign throughout the forecast period. Another key factor contributing to the recent increased demand for IVF treatment is delayed pregnancies in American women. Many women in the U.S try for a baby after they are well-settled in their career. This exceeds the age of motherhood to 35 years and above. As with the rising age, the chances of infertility increases. However, the desire for having a baby leads to these women opting for other alternate methods like in-vitro fertilization. Infertility rates in the Canadian women are also increasing. The Canadian market has also witnessed a rise in IVF and other ARTs (Assisted Reproduction Techniques) in recent years.

Some of the major companies involved in the in-vitro fertilization market are Halotech DNA, The Baker Company Inc, Auxogyn, Ovascience, Esco Micro Pte. Ltd, Thermo Fisher Scientific Inc, Cook Medical Inc, Irvine Scientific (Subsidiary Of Nippon Mining Holdings), Ferring Pharmaceuticals, Vitrolife Ab, Andrology Solutions, Genea, Merck Serono, Copper Surgical Inc, and Ivftech Aps.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
      • RESEARCH METHODOLOGY
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • INSURANCE COVERAGE FOR IVF
        • GROWTH OF MEDICAL TOURISM
    1. MARKET DYNAMICS
      • MARKET DEFINITION
      • DRIVERS
        • INCREASING RATE OF INFERTILITY ACROSS THE GLOBE
        • FLEXIBLE GOVERNMENT REGULATIONS FOR FERTILITY TOURISM
        • IMPROVED SURROGACY LAWS
        • HIGH SUCCESS RATES OF ADVANCED IN-VITRO FERTILIZATION TREATMENTS
      • RESTRAINTS
        • HIGH COST
        • COUNTRY WISE REGULATORY ISSUES
      • OPPORTUNITIES
        • INCREASING DEMAND FOR LOW-COST PROCEDURES
        • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
      • CHALLENGES
        • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
        • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE TO IVF
          • DIET AND SUPPLEMENTS
          • ACUPUNCTURE
          • THERAPY
          • QIGONG
    1. MARKET BY PRODUCT AND PROCEDURES
      • BY PRODUCT
        • REAGENTS
        • EQUIPMENTS
      • BY PROCEDURE
        • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
        • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
        • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
        • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS
    2. KEY ANALYTICS
      • PORTER’S 5 FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE PRODUCTS
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIERS
        • INTENSITY OF COMPETITIVE RIVALRY
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL PROCUREMENT
        • MANUFACTURING
        • SUPPLY LOGISTICS
        • DISTRIBUTION CHANNELS
        • END USERS
      • KEY BUYING CRITERIA
        • TREATMENT OPTIONS
        • QUALITY OF MEDICAL PROCEDURES
        • PRICE OF TREATMENTS
        • SHIFT TOWARDS MEDICAL TOURISM
        • REIMBURSEMENT
      • REGULATORY FRAMEWORK
      • INVESTMENT OUTLOOK
        • END-USER OUTLOOK
      • VENDOR LANDSCAPE
      • OPPORTUNITY MATRIX
    3. GEOGRAPHICAL ANALYSIS
      • US
      • CANADA
    4. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
        • VITROLIFE
        • COOPER SURGICAL
        • MERCK
        • COOK MEDICAL
        • FERRING PHARMACEUTICALS
      • TOP WINNING STRATEGIES
      • COMPANY PROFILES
        • ANDROLOGY SOLUTIONS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • AUXOGYN
          • OVERVIEW
          • PRODUCTS
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • COOK MEDICAL INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALY
          • STRATEGIC ANALYSIS
        • COPPER SURGICAL INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • ESCO MICRO PTE. LTD.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • FERRING PHARMACEUTICALS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • GENEA
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • HALOTECH DNA
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • IRVINE SCIENTIFIC (SUBSIDIARY OF NIPPON MINING HOLDINGS)
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • IVFTECH APS
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • MERCK SERONO
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • OVASCIENCE
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • THE BAKER COMPANY, INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • THERMO FISHER SCIENTIFIC INC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVE
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS
        • VITROLIFE AB
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
          • STRATEGIC ANALYSIS

    LIST OF TABLES

    TABLE 1 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY COUNTRY 2018-2026 ($ MILLION)

    TABLE 2 NORTH AMERICA IVF MARKET BY PRODUCT AND PROCEDURES 2018-2026 ($ MILLION)

    TABLE 3 NORTH AMERICA IVF MARKET BY PRODUCTS 2018-2026 ($ MILLION)

    TABLE 4 NORTH AMERICA IVF MARKET BY PROCEDURE 2018-2026 ($ MILLION)

    TABLE 5 NORTH AMERICA IVF MARKET BY END-USER 2018-2026 ($ MILLION)

    TABLE 6 NORTH AMERICA IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

     

    LIST OF FIGURES

    FIGURE 1 NORTH AMERICA IN-VITRO FERTILIZATION MARKET BY PROCEDURE 2018-2026 ($ MILLION)

    FIGURE 2 EVOLUTION OF IVF MARKET

    FIGURE 3 FALLING BIRTH RATE IN THE US (1960-2015)

    FIGURE 4 NORTH AMERICA REAGENTS MARKET 2018-2026 ($ MILLION)

    FIGURE 5 NORTH AMERICA EQUIPMENTS MARKET 2018-2026 ($ MILLION)

    FIGURE 6 NORTH AMERICA INTRA CYTOPLASMIC SPERM INJECTION (ICSI) MARKET 2018-2026 ($ MILLION)

    FIGURE 7 NORTH AMERICA PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET 2018-2026 ($ MILLION)

    FIGURE 8 NORTH AMERICA FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) MARKET 2018-2026 ($ MILLION)

    FIGURE 9 NORTH AMERICA OTHERS MARKET 2018-2026 ($ MILLION)

    FIGURE 10 NORTH AMERICA FERTILITY AND SURGICAL CENTERS MARKET 2018-2026 ($ MILLION)

    FIGURE 11 NORTH AMERICA HOSPITALS AND RESEARCH LABORATORIES MARKET 2018-2026 ($ MILLION)

    FIGURE 12 NORTH AMERICA CRYOBANKS MARKET 2018-2026 ($ MILLION)

    FIGURE 13 INVESTMENT PROPOSITION FOR NORTH AMERICA IVF MARKET BY END-USER – 2017

    FIGURE 14 CONTRACEPTIVE PREVALENCE AND UNMET NEED FOR FAMILY PLANNING AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS IN NORTH AMERICA IN (%) 2015

    FIGURE 15 NUMBER OF IVF CYCLES PERFORMED IN THE US

    FIGURE 16 UNITED STATES IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 17 FERTILITY RATE IN CANADA (NO. OF CHILD PER WOMEN)

    FIGURE 18 CANADA IVF MARKET 2018-2026 ($ MILLION)

    FIGURE 19 NORTH AMERICA IVF MARKET SHARE OF MAJOR COMPANIES – 2017

    1. GEOGRAPHICAL ANALYSIS
      • US
      • CANADA
    2. MARKET BY PRODUCT AND PROCEDURES
      • BY PRODUCT
        • REAGENTS
        • EQUIPMENTS
      • BY PROCEDURE
        • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
        • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
        • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
        • OTHERS
    1. MARKET BY END-USER
      • FERTILITY AND SURGICAL CENTERS
      • HOSPITALS AND RESEARCH LABORATORIES
      • CRYOBANKS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type